ArticlePharmacoEconomics - open2026

Assessing the Expected Costs of Continuous Remote Monitoring for Post-Discharge Home Use and the Readmission Reduction Required to Achieve Cost Neutrality.

Arendse Tange Larsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.